Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$6.81 - $9.74 $4.92 Million - $7.04 Million
-722,543 Closed
0 $0
Q2 2023

Aug 14, 2023

SELL
$6.67 - $9.52 $4.4 Million - $6.27 Million
-658,975 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$5.76 - $12.48 $4.03 Million - $8.73 Million
699,170 New
699,170 $4.85 Million
Q4 2022

Feb 14, 2023

BUY
$8.86 - $25.04 $6.91 Million - $19.5 Million
779,801 New
779,801 $8.02 Million
Q3 2022

Nov 13, 2023

BUY
$18.2 - $76.12 $13.2 Million - $55 Million
722,543 New
722,543 $13.2 Million
Q2 2022

Aug 14, 2023

BUY
$36.28 - $75.29 $23.9 Million - $49.6 Million
658,975 New
658,975 $33.9 Million
Q1 2022

May 12, 2023

SELL
$69.73 - $142.9 $11.2 Million - $22.9 Million
-160,432 Reduced 20.57%
619,369 $45.6 Million
Q1 2022

May 09, 2022

SELL
$69.73 - $142.9 $43 Million - $88.2 Million
-617,156 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$134.56 - $217.97 $83 Million - $135 Million
617,156 New
617,156 $88.3 Million
Q3 2021

Nov 14, 2022

BUY
$177.8 - $270.58 $113 Million - $172 Million
634,509 New
634,509 $132 Million
Q3 2021

Nov 05, 2021

SELL
$177.8 - $270.58 $107 Million - $162 Million
-599,354 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$121.0 - $257.67 $72.5 Million - $154 Million
599,354 New
599,354 $127 Million
Q2 2021

Aug 10, 2021

SELL
$121.0 - $257.67 $66.7 Million - $142 Million
-551,279 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$112.98 - $319.93 $62.3 Million - $176 Million
551,279 New
551,279 $100 Million
Q1 2021

May 07, 2021

SELL
$112.98 - $319.93 $63.1 Million - $179 Million
-558,692 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$78.74 - $139.5 $44 Million - $77.9 Million
558,692 New
558,692 $62.3 Million
Q4 2020

Feb 10, 2021

SELL
$78.74 - $139.5 $40.9 Million - $72.5 Million
-519,560 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$79.44 - $178.51 $41.3 Million - $92.7 Million
519,560 New
519,560 $56.3 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $630M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.